Companies / Exact Sciences Corp.

Exact Sciences Corp.

Nasdaq: EXASCIK 1124140MADISON, WIexactsciences.com ↗

Financials · FY2025

Revenue$3.25B
Net income$-207.95M
Total debt$50.00M
Cash$956.00M
Diluted EPS$-1.10
Shares outstanding190.9M

Ownership

190.9M shares outstanding · as of Feb 12, 2026
86.6%Institutions
Ownership
Institutions86.57%165,248,034
Public float13.43%25,640,177

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Baranick BrianEVP, GM, Precision Oncology
0.00%0
Barber Michael JDirector
0.00%0
Bloomer AaronEVP, Chief Financial Officer
0.00%0
Clancy Paul JDirector
0.00%0
Condella SarahEVP, Human Resources
0.00%0
Conroy Kevin TCEOPresident and CEO · Director
0.00%0
Coward D ScottDirector
0.00%0
Doyle James EdwardDirector
0.00%0
Herriott JamesSVP, General Counsel & Sec
0.00%0
Orville Jacob aEVP, GM, Screening
0.00%0

Institutional holders 703

View all →
HolderValue% of shares
Vanguard Group Inc$1.77B9.12%
BlackRock, Inc.$1.54B7.93%
Hbk Investments L P$776.59M4.01%
Pentwater Capital Management LP$736.31M3.80%
State Street Corporation$424.83M2.19%
Balyasny Asset Management L.P.$415.38M2.14%
Millennium Management LLC$349.52M1.80%
Norges Bank$348.43M1.80%
Geode Capital Management, LLC$338.43M1.75%
Morgan Stanley$330.10M1.70%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 27, 2026Conroy Kevin T
CEO
OtherCommon Stock$1.35M-13K
-1.01%
1,278,045
0.67% of shares
low
Feb 27, 2026Conroy Kevin T
CEO
OtherCommon Stock$1.08M-10K
-0.82%
1,263,319
0.66% of shares
low
Feb 27, 2026Conroy Kevin T
CEO
OtherCommon Stock$880.5K-9K
-0.68%
1,251,570
0.66% of shares
low
Feb 25, 2026Conroy Kevin T
CEO
OtherCommon Stock$641.0K-6K
-0.50%
1,241,955
0.65% of shares
low
Feb 27, 2026Condella Sarah
Executive
OtherCommon Stock$197.8K-2K
-1.44%
131,121
0.07% of shares
low
Feb 27, 2026Condella Sarah
Executive
ExerciseCommon Stock$19.6K+4K
+3.02%
133,034
0.07% of shares
low
Mar 23, 2026Condella Sarah
Executive
GrantCommon Stock$0+60K
+45.92%
191,891
0.10% of shares
low
Mar 23, 2026Conroy Kevin T
CEO
GrantCommon Stock$0+119K
+9.33%
1,397,738
0.73% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Capital World InvestorsPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
EXAS——30063P105—